TRANSPHORM INC (TGAN) Stock Cash Flow
NASDAQ:TGAN - Nasdaq - US89386L1008 - Common Stock - Currency: USD
| TTM (2023-12-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2020-12-31) | 2020 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -33.37M | -30.60M | -10.24M | -17.91M | -15.28M | |||
| Depreciation Amortization | 1.16M | 970.00K | 840.00K | 840.00K | 1.22M | |||
| Change In Working Capital | -280.00K | -6.38M | -5.95M | -780.00K | -3.42M | |||
| Interest Paid | N/A | 730.00K | 690.00K | 920.00K | 500.00K | |||
| Other non cash items | 10.19M | 9.50M | -4.39M | 3.74M | 5.20M | |||
| OPERATING CASH FLOW | -22.29M | -26.51M | -19.74M | -14.12M | -12.29M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.93M | -6.94M | -600.00K | -60.00K | -200.00K | |||
| Other Investing Activity | -1.51M | -3.21M | -4.53M | -7.35M | -2.70M | |||
| INVESTING CASH FLOW | -3.44M | -10.15M | -5.12M | -7.41M | -2.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | -50.00K | 15.00M | |||
| Stock Issued/Repurchased | 23.14M | 19.66M | 51.39M | 33.21M | N/A | |||
| Other Financing Activity | -1.04M | -830.00K | -1.90M | 4.00K | N/A | |||
| FINANCING CASH FLOW | 10.11M | 18.83M | 49.50M | 33.16M | 15.00M | |||
| Exchange Rate Effect | -80.00K | -90.00K | -210.00K | 180.00K | 0.00 | |||
| CHANGE IN CASH | -15.71M | -17.92M | 24.43M | 11.81M | -190.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -22.29M | -26.51M | -19.74M | -14.12M | -12.29M | |||
| Capital Expenditure | -1.93M | -6.94M | -600.00K | -60.00K | -200.00K | |||
| FREE CASH FLOW | -24.22M | -33.45M | -20.34M | -14.18M | -12.49M | |||
All data in USD